Ko, Dongjoon
49  Ergebnisse:
Personensuche X
?
1

Therapeutic effects of TM4SF5-targeting chimeric and humani..:

Ko, Dongjoon ; Kim, Eunmi ; Shin, Eun-Ae...
Molecular Therapy - Oncolytics.  24 (2022)  - p. 452-466 , 2022
 
?
3

Bioconjugated Thymol-Zinc Oxide Nanocomposite as a Selectiv..:

Shin, Joonho ; Naskar, Atanu ; Ko, Dongjoon..
International Journal of Molecular Sciences.  23 (2022)  12 - p. 6770 , 2022
 
?
5

Therapeutic effects of TM4SF5-targeting chimeric and humani..:

Dongjoon Ko ; Eunmi Kim ; Eun-Ae Shin...
http://www.sciencedirect.com/science/article/pii/S2372770522000109.  , 2022
 
?
6

Therapeutic effects of TM4SF5-targeting chimeric and humani..:

Ko, Dongjoon ; Kim, Eunmi ; Shin, Eun-Ae...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841960/.  , 2022
 
?
 
?
 
?
12

TMEM52B suppression promotes cancer cell survival and invas..:

Lee, Yunhee ; Ko, Dongjoon ; Yoon, Junghwa..
Journal of Experimental & Clinical Cancer Research.  40 (2021)  1 - p. , 2021
 
?
13

Orbital torque in magnetic bilayers:

Lee, Dongjoon ; Go, Dongwook ; Park, Hyeon-Jong...
Nature Communications.  12 (2021)  1 - p. , 2021
 
?
14

TMPRSS4 promotes cancer stem–like properties in prostate ca..:

Lee, Yunhee ; Yoon, Junghwa ; Ko, Dongjoon...
Journal of Experimental & Clinical Cancer Research.  40 (2021)  1 - p. , 2021
 
?
15

Deficiency of optineurin enhances osteoclast differentiatio..:

Xue, Peng ; Hu, Xiangxiang ; Chang, Emily...
Experimental & Molecular Medicine.  53 (2021)  4 - p. 667-680 , 2021
 
1-15